What can patients do to give input into clinical trial design?
Drug Discovery World
SEPTEMBER 12, 2022
Chaired by Karin Blumer, Director of Global Patient Engagement at Novartis, the first event in this track, called ‘Patient Engagement: Driving Patient Advocacy to Inform Patient Centric Development’, looked into the multi-layered importance of involving patients in the drug development process, particularly in this case for gene therapy.
Let's personalize your content